Conversion of stable renal allografts from CyA to azathioprine: a 5-year follow-up.
McLean
A
A
Department of Nephrology, Dialysis, and Transplantation, Royal Free Hospital, London, U.K.
Fernando
O
O
Varghese
Z
Z
Sweny
P
P
D001379:Azathioprine / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine